Literature DB >> 15034762

Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH).

U Bacher1, W Kern, C Schoch, W Hiddemann, T Haferlach.   

Abstract

Although interphase fluorescence in situ hybridization (FISH) is routinely used in chronic lymphocytic leukemia (CLL), differences in the chromosomal pattern with respect to morphological subtypes of CLL (typical CLL, CLL/PL, PLL) are still under debate. We studied 153 patients with CLL and correlated cytomorphology on peripheral blood stains with FISH analysis and other prognostic markers. The percentage of prolymphocytes was calculated as a continuous variable and followed published thresholds in parallel while being correlated to FISH analysis. Higher percentages of prolymphocytes were associated significantly with deletion of 17p13. Deletion of 17p13 was most frequently observed in patients with more than 30% prolymphocytes. Trisomy 12 was found mainly in cases with 6-30% prolymphocytes. The percentage of prolymphocytes did not correlate with deletions of 11q23 or with 13q14 abnormalities. In conclusion, we suggest that further research focus on the percentage of prolymphocytes in CLL. Doing so, biologically relevant thresholds for the percentages of prolymphocytes in the peripheral blood and their association to underlying genetic markers could be investigated together with other biologically and especially prognostic markers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034762     DOI: 10.1007/s00277-004-0869-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  3 in total

Review 1.  Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia.

Authors:  Gábor Méhes
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

2.  Multiplex ligation-dependent probe amplification versus multiprobe fluorescence in situ hybridization to detect genomic aberrations in chronic lymphocytic leukemia: a tertiary center experience.

Authors:  Eiman A Al Zaabi; Louis A Fernandez; Irene A Sadek; D Christie Riddell; Wenda L Greer
Journal:  J Mol Diagn       Date:  2010-01-21       Impact factor: 5.568

3.  Inside the chronic lymphocytic leukemia cell: miRNA and chromosomal aberrations.

Authors:  Anna Grenda; Agata A Filip; Ewa Wąsik-Szczepanek
Journal:  Mol Med Rep       Date:  2022-01-04       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.